No description
-
2019 (v1)PublicationUploaded on: February 14, 2024
-
2020 (v1)Publication
Introduction: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with an underlying immune-mediated and inflammatory pathogenesis. Innate immunity, in addition to the adaptive immune system, plays a relevant role in MS pathogenesis. It represents the immediate non-specific defense against infections through the...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Background: Since its approval, the use of alteplase had been limited to patients aged ≤80 years. Aims: TESPI trial had been designed to evaluate whether alteplase treatment within 3 h in patients with acute ischemic stroke aged >80 years resulted in favorable benefit/risk ratio compared with standard care. The meta-analysis of randomized...
Uploaded on: April 14, 2023